Exploring Cardio-Physician's Clinical Challenges and Outcomes in Managing Multimorbid Cardiac Patients by Cross-Sectional Analysis
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/056Keywords:
Multimorbidity, Cardiophysician perspectives , Clinical outcomes , Heart disease managementAbstract
Background: Cardiovascular multimorbidity creates complex patient management challenges that cardio-physicians must prosecute. The study aimed to evaluate cardio-physician viewpoints about clinical challenges and health outcomes from managing cardiac patients with multiple health conditions.
Methods: A cross-sectional observational study involving 40 cardio-physicians was conducted in a tertiary care hospital from February 2023 until May 2023. A validated questionnaire collected data regarding diagnostic dilemmas, therapeutic conflicts, coordination issues, outcome monitoring, and patient adherence in multimorbid environments. The researchers analyzed responses by using descriptive statistics and thematic analysis, and chi-square testing.
Results: A total of 86.8% of participants reported frequent diagnostic confusion because symptoms manifested similarly across various comorbid conditions. Medical patients face three primary difficulties and these include multiple medications (90%) alongside drug treatment restrictions (80%) and fragmented healthcare services (65%). Treatment outcomes suffered for more than half of the patients because their comorbidities led to care delays and changes. The majority of 85% of respondents said essential collaboration with nephrologists and endocrinologists together with geriatricians was required.
Conclusion: Multimorbid cardiac patients present multiple challenges to cardio-physician medical care providers. The treatment approach must address care separation while promoting specialized care interactions to build individual patient profiles because this strategy directly impacts patient health outcomes and quality of life.
References
Schuttner L, Hockett Sherlock S, Simons C, Ralston JD, Rosland AM, Nelson K, et al. Factors affecting primary care physician decision-making for patients with complex multimorbidity: a qualitative interview study. BMC Prim Care. 2022 Feb ;23(1):25. doi: 10.1186/s12875-022-01633-x.
Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023 Jun;44(23):2066-2077. doi: 10.1093/eurheartj/ehac395.
Orehovački H, Brajković A, Bićanić LA, Mucalo I. Polypharmacy - is there a cure for drug therapy problems? Croat Med J. 2023 Aug ;64(4):295-300. doi: 10.3325/cmj.2023.64.295.
Kuipers SJ, Nieboer AP, Cramm JM. Easier Said Than Done: Healthcare Professionals' Barriers to the Provision of Patient-Centered Primary Care to Patients with Multimorbidity. Int J Environ Res Public Health. 2021 Jun ;18(11):6057. doi: 10.3390/ijerph18116057.
Alfattani MA, Bakudam WA, Alharbi WI. Factors Influencing Patient-Centered Care and Shared Decision-Making in Primary Care Settings in Saudi Arabia: A Scoping Review. Cureus. 2024 Dec 21;16(12):e76142. doi: 10.7759/cureus.76142.
Hendriks JM, Jaarsma T. The multidisciplinary team approach in cardiovascular care. Eur J Cardiovasc Nurs. 2021 Nov ;20(2):91-92. doi: 10.1093/eurjcn/zvaa005.
Nasrawi D, Latimer S, Massey D, Gillespie BM. Delivery, barriers, and enablers to patient participation in inpatient cardiac rehabilitation following cardiac surgery: An integrative review. Aust Crit Care. 2023 May ;36(3):420-430. doi: 10.1016/j.aucc.2022.01.007.
Barreto J, Karathanasis SK, Remaley A, Sposito AC. Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use. Arterioscler Thromb Vasc Biol. 2021 Nov ;41(1):153-166. doi: 10.1161/ATVBAHA.120.315421.
Whitelaw S, Pellegrini DM, Mamas MA, Cowie M, Van Spall HGC. Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review. Eur Heart J Digit Health. 2021 Mar ;2(1):62-74. doi: 10.1093/ehjdh/ztab005.
Singh K, Bawa VS, Venkateshmurthy NS, Gandral M, Sharma S, Lodhi S, et al. Assessment of studies of quality improvement strategies to enhance outcomes in patients with cardiovascular disease. JAMA Netw Open. 2021 Jun;4(6):e2113375. doi: 10.1001/jamanetworkopen.2021.13375
Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, et al. Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease: a review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 Jul;8(4):406-419. doi: 10.1093/ehjcvp/pvac005
Duong MH, Gnjidic D, McLachlan AJ, Sakiris MA, Goyal P, Hilmer SN. The prevalence of adverse drug reactions and adverse drug events from heart failure medications in frail older adults: a systematic review. Drugs Aging. 2022 Jun;39(8):631-643. doi: 10.1007/s40266-022-00957-8
Tomkova K, Roman M, Adebayo AS, Sheikh S, Yusoff S, Gulston M, et al. Multimorbidity is associated with myocardial DNA damage, nucleolar stress, dysregulated energy metabolism, and senescence in cardiovascular disease. NPJ Aging. 2024 Nov;10(1):58. doi: 10.1038/s41514-024-00183-z
Burrows NR, Koyama AK, Choudhury D, Yu W, Pavkov ME, Nee R, et al. Age-related association between multimorbidity and mortality in US veterans with incident chronic kidney disease. Am J Nephrol. 2022 Oct;53(8-9):652-662. doi: 10.1159/000526254
van Deutekom C, Hendriks JML, Myrstad M, Van Gelder IC, Rienstra M. Managing elderly patients with atrial fibrillation and multimorbidity: call for a systematic approach. Expert Rev Cardiovasc Ther. 2024 Oct;22(10):523-536. doi: 10.1080/14779072.2024.2416666
Hendriks JM, Jaarsma T. The multidisciplinary team approach in cardiovascular care. Eur J Cardiovasc Nurs. 2021 Feb;20(2):91-92. doi: 10.1093/eurjcn/zvaa005
Machado AM, Leite F, Pereira MG. Integrated care in atrial fibrillation: a multidisciplinary approach to improve clinical outcomes and quality of life. Healthcare (Basel). 2025 Feb;13(3):325. doi: 10.3390/healthcare13030325
Suhail M, Saeed H, Saleem Z, Younas S, Hashmi FK, Rasool F, et al. Association of health literacy and medication adherence with health-related quality of life (HRQoL) in patients with ischemic heart disease. Health Qual Life Outcomes. 2021 Apr;19(1):118. doi: 10.1186/s12955-021-01761-5
Ghobadi P, Gholami M, Hasanvand S, Toulabi T, Moradifar N, Birjandi M. Effects of a multidisciplinary management program on symptom burden and medication adherence in heart failure patients with comorbidities: a randomized controlled trial. BMC Nurs. 2022 Dec;21(1):346. doi: 10.1186/s12912-022-01130-7
Lee KS, Oh O, Miller J, Hammash M, Thompson DR, Ski CF, et al. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study. Eur J Cardiovasc Nurs. 2022 Sep;21(7):687-693. doi: 10.1093/eurjcn/zvab13
Nissen NK, Aarhus R, Ørtenblad L. Dynamics of a specialized and complex health care system: exploring general practitioners' management of multimorbidity. Chronic Illn. 2022 Jun;18(1):155-168. doi: 10.1177/1742395320928403
Zelenak C, Nagel J, Bersch K, Derendorf L, Doyle F, Friede T, et al. Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study. ESC Heart Fail. 2023 Mar;10(3):2051-2065. doi: 10.1002/ehf2.14294
Otieno P, Agyemang C, Wao H, Wambiya E, Ng'oda M, Mwanga D, et al. Effectiveness of integrated chronic care models for cardiometabolic multimorbidity in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Open. 2023 Jun;13(6):e073652. doi: 10.1136/bmjopen-2023-073652
Marques MDC, Pires R, Perdigão M, Sousa L, Fonseca C, Pinho LG, et al. Patient-centered care for patients with cardiometabolic diseases: an integrative review. J Pers Med. 2021 Dec;11(12):1289. doi: 10.3390/jpm11121289
Stuijt PJC, Heringa M, van Dijk L, Faber A, Burgers JS, Feenstra TL, et al. Effects of a multicomponent communication training to involve older people in decisions to deprescribe cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation. BMC Prim Care. 2024 Jun;25(1):210. doi: 10.1186/s12875-024-02465-7
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
